# Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade Gliomas

> **NCT01653834** · NA · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 10 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **PROCEDURE:** Lymphocyte harvesting & reinfusion

## Key facts

- **NCT ID:** NCT01653834
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2014-01
- **Final completion:** 2014-03
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01653834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01653834, "Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade Gliomas". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT01653834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*